Big Moving Stock keep track of the biggest moving stocks in the market.
The Hot Industries
Independent Oil & Gas 4
REIT - Retail 2
Oil & Gas Drilling & Exploration 2
The Hot Sectors
Basic Materials 8
ARIA Ariad Pharmaceuticals Inc.
ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors. Iclusig is a tyrosine kinase inhibitor (TKI) that is approved in the United States for the treatment of adult patients with chronic, accelerated, or blast phase chronic myeloid leukemia, who are resistant or intolerant to prior TKI therapy, as well as for the treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia, who are resistant or intolerant to prior TKI therapy. Its product pipeline consists of AP26113, an investigational dual inhibitor of anaplastic lymphoma kinase, which is being studied in a phase I/II clinical trial in patients with advanced solid tumors comprising non-small cell lung cancer; Ridaforolimus, an investigational mTOR inhibitor, which is being studied in multiple clinical trials in patients with various types of cancers; and AP1903, a small-molecule dimerizer drug. The company sells and markets Iclusig through specialty pharmacies and specialty distributors in the United States. It has collaboration and license agreement with Merck & Co., Inc. for the development, manufacture, and commercialization of ridaforolimus, for use in cancer; and license agreements with Medinol Ltd. and ICON Medical Corp. to develop and commercialize stents and other medical devices to deliver ridaforolimus. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is headquartered in Cambridge, Massachusetts.
InPlay from Briefing.com24 Apr 2014, 5:44 pmInPlay from Briefing.com
Mallinckrodt to Buy Drugmaker Questcor Pharmaceuticals for about $5.6B; Tesla Rated “Outperform” by RW Baird7 Apr 2014, 10:10 pmAriad Pharmaceuticals Inc. (NASDAQ: ARIA) – For an in-depth report on Ariad Pharmaceuticals Inc. follow: www.BullTrends.com/stockquote/ARIA
Coal India turns red hot6 Apr 2014, 11:15 amTHE HINDU Coal being transported in a lorry in the coal belt aria of Singareni Collieries Company Limited (SCCL).
Apollo Education Sinks on Disappointing Earnings; Rubicon Project Makes Grand Debut on NYSE2 Apr 2014, 10:10 pmThe Rubicon Project, Inc. (NYSE: RUBI) – For an in-depth report on the Rubicon Project, Inc. follow: www.BullTrends.com/stockquote/RUBI
Option Clips: Ariad Pharmaceuticals, Liquidity Services, and Gogo2 Apr 2014, 11:29 amTwo equities generating buzz on StockTwits today are oncology concern Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) and onlin ... ( Read More )
4 Stocks Under $10 Moving Higher2 Apr 2014, 4:31 amDELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers. >>5 Hated Earnings Stocks You Should Love Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making ...
Newmont Mining Corp Denies Cutting Output; Indonesian Copper and Gold Mine and Ford Raised CEO Alan Mulally’s ...30 Mar 2014, 10:10 pmAriad Pharmaceuticals Inc. (NASDAQ: ARIA) - For an in-depth report on Ariad Pharmaceuticals Inc. follow: www.BullTrends.com/stockquote/ARIA
Option Clips: Ariad Pharmaceuticals, MannKind, and Kroger28 Mar 2014, 12:15 pmTwo equities generating buzz on StockTwits today are oncology concern Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) and bioph ... ( Read More )
Press Release28 Mar 2014, 12:09 pmRegeneRx Biopharmaceuticals Inc. Posted on: 28 Mar 14 RegeneRx Biopharmaceuticals Inc. (OTC: RGRX) (â€œthe Companyâ€� or â€œRegeneRxâ€�) today announced that it received the initial $1.35 million payment pursuant to its product license and securities purchase agreement with G-treeBNT Co. Ltd (formerly Digital Aria Co. Ltd.) headquartered in Gyeonggi-do Korea for G-treeBNT to develop RegeneRxâ€™s ...
RDInvesting Provides Investors with Free In-Depth Equity Reports on ARIA, DYAX, GERN and T26 Mar 2014, 6:50 amResearch Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get ...